Jagrati Mathur

Learn More
The anti-tumor necrosis factor-α (TNF) antibodies have revolutionized the management of ulcerative colitis and Crohn's disease. The development of assays to allow for the measurements of serum drug levels and anti-drug antibodies have provided a more objective means of therapeutic decision making, particularly among patients losing response to treatment.(More)
This study reports the investigation and treatment of 31 patients who suffered symptoms suggestive of extracranial cerebrovascular disease and presented to one community practice. It suggests that extracranial cerebrovascular disease may be more prevalent than is generally presumed, and emphasizes the need for better methods of investigation and a more(More)